⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GYRE News
Gyre Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
GYRE
Global Acute-on-Chronic Liver Failure (ACLF) - Drug Pipeline Insight, 2026 | Phase II Assets and Unmet Need Drive R&D, Licensing, and Partnership Opportunities
globenewswire.com
GYRE
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
globenewswire.com
GYRE
Form 8-K
sec.gov
GYRE
Form 8-K
sec.gov
GYRE
Form 8-K
sec.gov
GYRE
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
globenewswire.com
GYRE
Form 8-K
sec.gov
GYRE
AMGN
AZN
Gyre Therapeutics Appoints Three New Members to its Board of Directors
globenewswire.com
GYRE
Form 8-K/A
sec.gov
GYRE